CH576427A5 - - Google Patents

Info

Publication number: CH576427A5
Authority: CH; Switzerland

Application number

CH1416772A

Original Assignee

Boehringer Mannheim Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-10-01

Filing date

1972-09-27

Publication date

1976-06-15

1971-10-01 Priority claimed from DE19712149070 external-priority patent/DE2149070C3/de

1972-09-27 Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh

1976-06-15 Publication of CH576427A5 publication Critical patent/CH576427A5/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CH1416772A 1971-10-01 1972-09-27 CH576427A5 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19712149070 DE2149070C3 (de)	1971-10-01	1971-10-01	Phenoxyalkylcarbonsäurederivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel
DE2230383A DE2230383C3 (de)	1971-10-01	1972-06-22	Phenoxyalkylcarbonsäurederivate und Verfahren zur Herstellung derselben

Publications (1)

Publication Number	Publication Date
CH576427A5 true CH576427A5 (es)	1976-06-15

Family

ID=25761810

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH1416772A CH576427A5 (es)	1971-10-01	1972-09-27

Country Status (18)

Country	Link
US (1)	US3781328A (es)
JP (1)	JPS5112618B2 (es)
AR (1)	AR193131A1 (es)
AT (1)	AT319209B (es)
BE (1)	BE857160Q (es)
CA (1)	CA1010892A (es)
CH (1)	CH576427A5 (es)
DE (1)	DE2230383C3 (es)
ES (1)	ES407208A1 (es)
FI (1)	FI55493C (es)
FR (1)	FR2154739B1 (es)
GB (1)	GB1359264A (es)
HK (1)	HK41877A (es)
HU (1)	HU164572B (es)
KE (1)	KE2755A (es)
NL (1)	NL146793B (es)
SE (1)	SE393800B (es)
YU (1)	YU36291B (es)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3864366A (en) *	1971-12-29	1975-02-04	Eastman Kodak Co	Novel acylamidophenol photographic couplers
GB1484413A (en) *	1974-04-18	1977-09-01	Kissei Pharmaceutical	Aromatic amidocarboxylic acid derivatives
DE2500157C2 (de) *	1975-01-03	1983-09-15	Hoechst Ag, 6230 Frankfurt	N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
US4042711A (en) *	1975-01-09	1977-08-16	Boehringer Ingelheim Gmbh	Derivatives of biphenyloxy-lower alkanoic acids, salts thereof and their use as antihyperlipidemics
AT341512B (de) *	1975-01-09	1978-02-10	Thomae Gmbh Dr K	Verfahren zur herstellung von neuen biphenylathern
DE2517229A1 (de) *	1975-04-18	1976-10-28	Boehringer Mannheim Gmbh	Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
DE2532420A1 (de) *	1975-07-19	1977-02-03	Boehringer Mannheim Gmbh	Phenylessigsaeure-derivate und verfahren zu ihrer herstellung
DE2541342A1 (de) *	1975-09-17	1977-03-31	Boehringer Mannheim Gmbh	Neue phenoxyalkylcarbonsaeuren und verfahren zur herstellung derselben
DE2546996C2 (de) *	1975-10-21	1984-07-05	Boehringer Mannheim Gmbh, 6800 Mannheim	Phenoxyalkylcarbonsäure-Derivate, Verfahren zur Herstellung derselben sowie Arzneimittel, die diese Verbindungen als Wirkstoff enthalten
US4214094A (en) *	1977-03-30	1980-07-22	Fujisawa Pharmaceutical Co., Ltd.	Substituted-phenyl substituted-alkyl ethers and the preparation thereof
JPS5649906B2 (en) *	1978-05-12	1981-11-25	Boehringer Mannheim Gmbh	Manufacture of alphaa4444chlorobenzoylaminoo ethylphenoxyisoethylacetic acid
JPS56145261A (en) *	1980-04-10	1981-11-11	Kaken Pharmaceut Co Ltd	Novel oxyacetic acid derivative, its preparation, and lowering agent of lipid in blood comprising it as active ingredient
US4281190A (en) *	1980-08-14	1981-07-28	Morton-Norwich Products, Inc.	Process for preparing N-[2-(p-hydroxyphenyl)-ethyl]-p-chlorobenzamide
JPS57140754A (en) *	1981-02-24	1982-08-31	Kureha Chem Ind Co Ltd	Dihydroxybenzoic acid derivative and physiologically active preparation containing the same
EP0303546B1 (fr) *	1987-08-12	1994-12-28	Sanofi	Procédé pour la O-alkylation de N-(hydroxy)aralkylphényléthanolamines
IL102707A (en) *	1992-08-02	1996-11-14	Cherkez Stephen	Processes for the preparation of tyramine derivatives
US6268392B1 (en)	1994-09-13	2001-07-31	G. D. Searle & Co.	Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6642268B2 (en)	1994-09-13	2003-11-04	G.D. Searle & Co.	Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6262277B1 (en) *	1994-09-13	2001-07-17	G.D. Searle And Company	Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6083497A (en) *	1997-11-05	2000-07-04	Geltex Pharmaceuticals, Inc.	Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
KR20010099937A (ko)	1998-12-23	2001-11-09	윌리암스 로저 에이	심혈관 징후용 콜레스테릴 에스테르 전달 단백질 억제제및 피브르산 유도체의 조합물
JP2002533413A (ja) *	1998-12-23	2002-10-08	ジー．ディー．サールエルエルシー	心臓血管に適用するための回腸胆汁酸輸送阻害剤およびフィブリン酸誘導体の組み合わせ
EA200100704A1 (ru) *	1998-12-23	2002-02-28	Джи.Ди.Сирл Ллс	Комбинация для применения по сердечно-сосудистым показаниям
ATE242007T1 (de)	1998-12-23	2003-06-15	Searle Llc	Kombinationen von cholesteryl ester transfer protein inhibitoren und nicotinsäure derivaten für kardiovaskuläre indikationen
DK1140185T3 (da)	1998-12-23	2003-09-29	Searle Llc	Kombinationer af cholesterylestertransferhæmmere og galdesyre kompleksdannende forbindelser til hjertekar indikationer
EP1342475A1 (en)	1998-12-23	2003-09-10	G.D. Searle LLC.	Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
US6462091B1 (en)	1998-12-23	2002-10-08	G.D. Searle & Co.	Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications
KR20010102965A (ko)	1998-12-23	2001-11-17	윌리암스 로저 에이	심장혈관의 징후에 대한 회장 담즙산 수송 저해제 및담즙산 격리제의 병용
AU2001236457A1 (en) *	2000-01-13	2001-07-24	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
AU2001240115A1 (en)	2000-03-10	2001-09-24	Pharmacia Corporation	Method for the preparation of tetrahydrobenzothiepines
AU2001247331A1 (en) *	2000-03-10	2001-09-24	Pharmacia Corporation	Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
US6982251B2 (en) *	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
EP1911462A3 (en)	2001-01-26	2011-11-30	Schering Corporation	Compositions comprising a sterol absorption inhibitor
MEP27808A (en) *	2001-01-26	2010-10-10	Schering Corp	Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
ATE331512T1 (de) *	2001-01-26	2006-07-15	Schering Corp	Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
IL156585A0 (en) *	2001-01-26	2004-01-04	Schering Corp	Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
JP2004517920A (ja) *	2001-01-26	2004-06-17	シェーリング　コーポレイション	血管状態を治療するためのステロール吸収阻害剤と血液調整剤との組合せ
MXPA03006727A (es) *	2001-01-26	2003-10-24	Schering Corp	Combinaciones de acido nicotinico y derivados del mismo con inhibidor(es) de la absorcion de los esteroles, y tratamiento para indicaciones vasculares.
EP1363668B1 (en) *	2001-01-26	2007-08-15	Schering Corporation	Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US7071181B2 (en) *	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
AR038956A1 (es) *	2001-05-25	2005-02-02	Schering Corp	Uso de un compuesto que regula la produccion o niveles de peptidos beta amiloides para la manufactura de un medicamento para tratar la enfermedad de alzheimer y/o para regular dichos niveles de peptidos amiloides beta en un sujeto
US20040077625A1 (en) *	2001-07-25	2004-04-22	Tremont Samuel J.	Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake
JP2005504091A (ja) *	2001-09-21	2005-02-10	シェーリング　コーポレイション	ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US20030119808A1 (en) *	2001-09-21	2003-06-26	Schering Corporation	Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
ES2312624T3 (es) *	2001-09-21	2009-03-01	Schering Corporation	Metodos para tratar o prevenir la inflamacion vascular usando un inhibidor (inhibidores) de la absorcion de esterol.
US7053080B2 (en) *	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) *	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
JP2005518347A (ja) *	2001-11-02	2005-06-23	ジー．ディー．サールエルエルシー	頂端ナトリウム共依存性胆汁酸輸送（ａｓｂｔ）およびタウロコール酸塩取り込みの阻害剤としての新規一および二フッ化ベンゾチエピン化合物
EP1465885A4 (en)	2002-01-17	2005-04-27	Pharmacia Corp	NOVEL ALKYL / ARYL HYDROXY OR CETOTHIEPINE COMPOUNDS AS INHIBITORS OF BILIARY ACID TRANSPORT OF THE ILEAL TYPE AND ABSORPTION OF TAUROCHOLATE
WO2004043457A1 (en) *	2002-11-06	2004-05-27	Schering Corporation	Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
MXPA05009501A (es)	2003-03-07	2005-10-18	Schering Corp	Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
CA2517571C (en) *	2003-03-07	2011-07-05	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7459442B2 (en)	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1606287B1 (en) *	2003-03-07	2013-10-02	Merck Sharp & Dohme Corp.	Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
CA2526730A1 (en)	2003-05-30	2004-12-09	Ranbaxy Laboratories Limited	Substituted pyrrole derivatives
WO2004108126A1 (en) *	2003-06-06	2004-12-16	Snowden Pharmaceuticals, Llc	Fibric acid derivatives for the treatment of irritable bowel syndrome
WO2005046797A2 (en) *	2003-11-05	2005-05-26	Schering Corporation	Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
JP2009514851A (ja)	2005-11-08	2009-04-09	ランバクシーラボラトリーズリミテッド	（３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
FR2898894B1 (fr) *	2006-03-24	2008-06-06	Genfit Sa	Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
FR2898892A1 (fr) *	2006-03-24	2007-09-28	Genfit Sa	Derives de n-(phenethyl)benzamide substitues,preparation et utilisations
US20100210633A1 (en) *	2006-10-12	2010-08-19	Epix Delaware, Inc.	Carboxamide compounds and their use
EP2134169A2 (en)	2007-03-09	2009-12-23	Indigene Pharmaceuticals Inc.	Combination of metformin r-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
WO2009076404A1 (en) *	2007-12-10	2009-06-18	Epix Delaware, Inc.	Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
EP2280766A1 (en)	2007-12-11	2011-02-09	CytoPathfinder, Inc.	Carboxamide compounds and their use as chemokine receptor agonists
US20130156720A1 (en)	2010-08-27	2013-06-20	Ironwood Pharmaceuticals, Inc.	Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
TN2017000344A1 (en)	2015-02-06	2019-01-16	Intercept Pharmaceuticals Inc	Pharmaceutical compositions for combination therapy
JP7305548B2 (ja)	2017-11-15	2023-07-10	日本ケミファ株式会社	ペルオキシソーム増殖剤応答性受容体活性化剤
KR20220016146A (ko)	2019-05-30	2022-02-08	인터셉트 파마슈티컬즈, 인크.	담즙정체성 간 질환의 치료에서 사용하기 위한 fxr 효능제 및 피브레이트를 포함하는 제약 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1080503A (en) *	1965-07-02	1967-08-23	Smith & Nephew	Substituted acetic acids and a process for their preparation

1972
- 1972-06-22 DE DE2230383A patent/DE2230383C3/de not_active Expired
- 1972-09-07 US US00287114A patent/US3781328A/en not_active Expired - Lifetime
- 1972-09-25 FI FI2626/72A patent/FI55493C/fi active
- 1972-09-25 NL NL727212931A patent/NL146793B/xx not_active IP Right Cessation
- 1972-09-26 AR AR244285A patent/AR193131A1/es active
- 1972-09-26 SE SE7212397A patent/SE393800B/xx unknown
- 1972-09-27 GB GB4461172A patent/GB1359264A/en not_active Expired
- 1972-09-27 CH CH1416772A patent/CH576427A5/xx not_active IP Right Cessation
- 1972-09-28 YU YU2455/72A patent/YU36291B/xx unknown
- 1972-09-29 FR FR7234605A patent/FR2154739B1/fr not_active Expired
- 1972-09-29 AT AT840872A patent/AT319209B/de not_active IP Right Cessation
- 1972-09-29 HU HUBO1396A patent/HU164572B/hu unknown
- 1972-09-29 CA CA152,967A patent/CA1010892A/en not_active Expired
- 1972-09-30 ES ES407208A patent/ES407208A1/es not_active Expired
- 1972-10-02 JP JP47098866A patent/JPS5112618B2/ja not_active Expired
1977
- 1977-07-26 BE BE179642A patent/BE857160Q/xx not_active IP Right Cessation
- 1977-08-02 KE KE2755A patent/KE2755A/xx unknown
- 1977-08-11 HK HK418/77A patent/HK41877A/xx unknown

Also Published As

Publication number	Publication date
AR193131A1 (es)	1973-03-30
FR2154739B1 (es)	1975-10-31
YU36291B (en)	1982-06-18
DE2230383A1 (de)	1974-01-17
CA1010892A (en)	1977-05-24
DE2230383C3 (de)	1981-12-03
YU245572A (en)	1980-10-31
SE393800B (sv)	1977-05-23
ES407208A1 (es)	1975-11-01
NL146793B (nl)	1975-08-15
NL7212931A (es)	1973-04-03
US3781328A (en)	1973-12-25
FI55493C (fi)	1979-08-10
KE2755A (en)	1977-10-14
HU164572B (es)	1974-03-28
DE2230383B2 (de)	1980-10-09
AU4723372A (en)	1973-08-23
GB1359264A (en)	1974-07-10
HK41877A (en)	1977-08-19
FI55493B (fi)	1979-04-30
FR2154739A1 (es)	1973-05-11
AT319209B (de)	1974-12-10
BE857160Q (fr)	1978-01-26
JPS4840741A (es)	1973-06-15
JPS5112618B2 (es)	1976-04-21

Publication	Publication Date	Title
FR2122883A5 (es)	1972-09-01
FR2154739B1 (es)	1975-10-31
FR2124348A1 (es)	1972-09-22
FI46651B (es)	1973-01-31
FR2124551A1 (es)	1972-09-22
FR2122015A5 (es)	1972-08-25
FR2114413A5 (es)	1972-06-30
FR2122410A1 (es)	1972-09-01
FR2122353A1 (es)	1972-09-01
FR2124235A1 (es)	1972-09-22
FR2106336A2 (es)	1972-05-05
DK140261C (es)	1979-12-10
FR2120521A5 (es)	1972-08-18
CS158319B1 (es)	1974-11-25
CS148673B1 (es)	1973-03-29
CS149159B1 (es)	1973-05-24
CS164387B1 (es)	1975-11-07
CS153834B1 (es)	1974-03-29
CS151279B1 (es)	1973-09-17
CS148270B1 (es)	1973-02-22
CH576981A5 (es)	1976-06-30
CH562403A5 (es)	1975-05-30
CH560125A5 (es)	1975-03-27
CH547895A (es)	1974-04-11
BG17238A1 (es)	1973-07-25

Legal Events

Date	Code	Title	Description
1992-11-30	PL	Patent ceased
2024-10-31	PL	Patent ceased